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Abstract
Alcohol is one of the most abused substances worldwide. The regular consumption of
alcohol can lead to dependency which depresses the central nervous system.
Consequently, when a heavy drinker is no longer consuming alcohol, the central nervous
system is no longer suppressed and may go into a hyperexcitable state known as alcohol
withdrawal syndrome (AWS). Symptoms can vary from mild to life threatening. Patients
who experience alcohol withdrawal symptoms often have a more complicated
hospitalization, an extended length of stay, and increased utilization of intensive care and
medical services. The Clinical Institute Withdrawal Assessment of Alcohol Scale-revised
(CIWA-Ar) is a tool that can be used to objectively assess patients for the development of
AWS. By using the CIWA-Ar to assess patients, nurses can quantify the potential for the
development of AWS and therefore initiate treatment for patients who require therapy.
The purpose of this research is to evaluate the impact that CIWA-Ar has on care provided
by healthcare professionals.
Keywords: alcohol dependency, alcohol withdrawal, alcohol withdrawal syndrome,
CIWA-Ar
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Chapter 1 – Statement of the Problem
Introduction
Alcohol is one of the most widely consumed intoxicants in our nation. According
to the Centers for Disease and Prevention (CDC) nearly 88,000 people (approximately
62,000 men and 26,000 women) die from alcohol related causes annually, making it the
third leading preventable cause of death in the United States (CDC, 2014). The National
Institute on Alcohol Abuse and Alcoholism (NIAA) defines heavy drinking as drinking
five or more drinks on the same occasion on each of five or more days in the past 30 days
(2014). Individuals that consume alcohol on a regular basis are at risk for developing
alcohol withdrawal syndrome (AWS) when they are hospitalized.
When alcohol intake is reduced or stopped completely, the neurotransmitters that
were previously suppressed rebound and alcohol withdrawal syndrome can occur which
produces a hyperautonomic state known as AWS (Karriem-Norwood, 2013). Symptoms
of AWS can vary from mild such as headaches to severe such as delirium tremens. There
are a variety of pharmacological treatments used to prevent those at risk for AWS. There
is a need for more research to determine the usefulness of AWS prevention protocols
such as the clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) in order
to avert complications, prolonged hospitalization, and possible death.
The CIWA-Ar is a tool that clinically calculates the severity of AWS and can be
used to monitor response to treatment. Use of the scale can be incorporated into the usual
care of patients undergoing alcohol withdrawal. The scale is useful as a research tool in
quantitating the efficacy of drugs used in the treatment of alcohol withdrawal. The
researcher is employed at the Central Arkansas Veterans Healthcare System (CAVHS)
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which uses the CIWA-Ar. At CAVHS, medical doctors (MDs) have an automatic order
set that can be used concurrently with the CIWA-Ar. The order set consists of nursing
orders, blood laboratory orders, and pharmacological treatments for the patients (Figure
4). This set allows nurses to follow a set of orders without the need to contact doctor
whenever interventions are required. The researcher is interested in learning the effect
that the CIWA-Ar tool, protocol and order set have on healthcare providers.
Background of the Problem
The use of alcohol depresses the central nervous system by concurrently
increasing inhibitory functions and reducing excitatory functions. In order to sustain
equilibrium, a heavy drinker needs a continual presence of alcohol in his or her system.
Prolonged use of alcohol leads to tolerance and sedation. As this occurs, the person
remains alert at alcohol concentrations that would produce lethargy in others (Roberson,
2014). Chronic alcohol consumption also suppresses the activity of glutamate, the
neurotransmitter which produces feelings of excitability. To preserve homeostasis, the
glutamate system operates by working at a far higher level than it does in moderate
drinkers and nondrinkers. When alcohol intake is reduced or stopped completely, the
neurotransmitters that were previously suppressed rebound and alcohol withdrawal
syndrome can occur, which produces a hyperautonomic state (Karriem-Norwood, 2013).
Signs and symptoms of withdrawal are most likely to reach its highest intensity
48 hours after the last drink; however, there is a diverse variation in the onset, severity,
and duration of symptoms. Symptoms of withdrawal usually occur 6 -12 hours after the
last drink and can be relieved by ingesting additional alcohol. If left untreated, symptoms
can range from mild to life threatening. Patients suffering from alcohol withdrawal
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syndrome are more likely to have a prolonged hospital stay due to this condition. In
addition, patients are at risk of developing other complications such as, head injuries,
cardiac failure, or pneumonia (Hendey, Dery, Barnes, Snowden, & Mentler, 2011).
Purpose of Study
By using the CIWA-Ar to assess patients, nurses can quantify the potential for the
development of AWS and therefore initiate pharmacological treatment for patients who
necessitate therapy. The scale identifies the minimal clinical features and converts the
Diagnostic and Statistical Manual of Mental Disorders (DSM) items into scores for
tracking severity over time and thus is essential to clinical research. Individualizing
therapy according to the signs and symptoms of each patient should result in
administration of less medication and shorter treatment. The CIWA-Ar can be used to
provide guidance and to monitor treatment of AWS. The objectives of health informatics
are to improve quality of care, lower medical costs, and increase patient satisfaction. If
the use of CIWA-Ar protocol is found to be beneficial then it will fulfill the health
informatics aims by effectively managing symptoms of AWS and in turn reducing length
of hospitalization stays. The purpose of this research is to evaluate the impact of utilizing
CIWA-Ar has on care provided by healthcare professionals. By analyzing data from a
survey of doctors and nurses, this study aims to determine if the impact of CIWA-Ar is
perceived as positive or negative by healthcare professionals that are caring for patients
with AWS.
Significance of Study
The clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)
protocol is used as a prevention method to stop the progression of AWS in moderate to
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high risk patients. The CIWA-Ar protocol has a set of ordered guidelines and medical
interventions that the healthcare providers use that is established by a scale that scores the
patient based upon the physiological alcohol withdrawal symptoms that he or she
displays (Department of Veteran Affairs, 2012).
The CIWA-Ar scale is considered the most sensitive tool available for assessment
of the patient experiencing alcohol withdrawal. With the CIWA-Ar protocol, there are
ten criteria assessed hourly for moderate to high risk patients to determine if they are
displaying signs and symptoms of AWS (Figure 2). Each criterion has a scale of 0 - 7.
The measures are as follows: nausea/vomiting, tremors, anxiety, agitation, paroxysmal
sweats, orientation, tactile disturbances, auditory disturbances, visual disturbances, and
headache. A score of 0-9 indicates absent/minimal withdrawal. A score of 10-19
indicates mild to moderate withdrawal. A score of more than 20 indicates severe
withdrawal. Early intervention for CIWA-Ar score of 10 or greater provides a method to
inhibit the progression of AWS. Interventions include, but are not limited to: providing
the patient with a multivitamin supplement that alcohol users often have a deficiency in
and treating symptoms with benzodiazepines as indicated.
There are a variety of treatment approaches used to prevent and treat AWS.
Alcohol is one of the most extensively used substances in this country. Unfortunately,
there are individuals that develop alcohol dependence which can lead to physiological
and psychological impairment if their use of alcohol is abruptly interrupted without
tapering off the amount of intake slowly. There is a need to research the effectiveness of
the CIWA-Ar protocol in moderate to high risk patients for AWS in order to determine if
it is the best intervention to prevent and treat AWS.

11

IMPACT OF CIWA-AR ON HEALTHCARE PROFESSIONALS
Research Question
What impact does the Clinical Institute Withdrawal Assessment for Alcohol
scale-revised (CIWA-Ar) have on care provided by healthcare professionals?
Definition of Terms
Alcohol withdrawal syndrome (AWS) is a set of physiological and psychological
symptoms that can manifest when an individual limits or stops alcoholic consumption
after long periods of use.
The clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) is an
assessment tool with a set of guidelines to manage AWS.
Limitations
The research will be acquired through a survey evaluation. This environment will
be uncontrolled by the researcher. The survey will have more validity according to the
number of responses are received. The patients’ complications, pharmacological
treatments and length of stay can be affected by other comorbidities which may alter
healthcare providers’ views of the CIWA-Ar. The literature review shows that there has
not been much research done specifically on this topic to compare to. Please refer to
Appendix A for the researcher’s SWOT analysis that indicates further limitations as well
as strengths of this research.
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Chapter 2 – Review of the Literature
Overview
This literature review consists of evidence based research journal articles that
examine the usefulness of alcohol withdrawal risk protocols and the effectiveness of
pharmacological treatment of AWS.
Methods
Electronic databases were used to retrieve relevant journal articles and research.
Searches were limited to the English language and articles used were dated no later than
2006. CINAHL with full text, PubMed, Google Scholar, Education Resource Information
Center (ERIC), and Ovid were used to conduct the literature searches. Keywords used for
the search were: alcohol withdrawal syndrome, alcohol dependency, alcohol misuse,
alcohol withdrawal, alcoholism, hospitalization, substance treatment, CIWA-Ar protocol.
Figure 1 consists of a flow sheet displaying this process.
Data Selection
The articles were chosen based upon criteria that pertained to: alcohol withdrawal,
pharmacological treatments for the prevention and treatment of alcohol withdrawal, the
effectiveness of pharmacological treatment of AWS. Articles were not selected if they
did not meet the aforementioned measures. Table 1 summarizes the seven studies that
were retained after the review of abstracts and full text evaluation.
Results
Awissi, Lebrun, Coursin, Riker and Skrobik (2012) determined in their reflective
study of adult ICU patients at risk for AWS should undergo early and aggressive
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treatment with pharmacological medications [benzodiazepines, alpha-2 agonists,
antipsychotics]. These medications should be titrated to specific withdrawal symptoms in
order to prevent complications of AWS.
Fullwood, Mostaghimi, Granger, Washam, Bride, Zhao, and Granger (2013)
concluded in their study of 57 adult myocardial infarction patients with high risk of AWS
that early screening and prompt therapy may curtail intensive care unit resource use for
alcohol withdrawal. In their study, there was not a significant difference in complications
or length of stay with the treatment of lorazepam or ethanol.
Murdoch and Marsden (2014) deduced in their study of 50 adult inpatients that by
having patients assessed early and on a frequent basis as well as educating staff;
management of AWS can be more effective with less pharmacological agents required
and less severity of complications.
Muzyk, Fowler, Norwood, and Chilipko (2011) found in their reflective study of
adult inpatients diagnosed with AWS that clonidine only affected the mild-to-moderate
AWS sympathetic complications, however, it did not prevent the severe symptoms of
delirium and seizures. However, they discovered that dexmedetomidine successfully
treated all of the alcohol withdrawal symptoms soon after initiation of treatment.
Prince and Turpin (2008) concluded in their reflective study of adult patients
diagnosed with AWS that nitrous oxide is contraindicated for use of treatment of AWS
and there are limitations on current evidence of the use of carbamazepine and gabapentin
for treatment.
Sohraby, Attridge, and Hughes (2014) discovered in their study of 64
mechanically ventilated patients diagnosed with AWS that there was not a significant
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difference in length of stay, length of required mechanical ventilation, and length of
hospitalization.
Taheri, Dahri, Chan, Shaw, Aulakh, and Tashakkor (2014) deduced in their study
of 99 elderly individuals, age 70 years and older, found that by implementing the CIWAAr protocol significantly reduced the need amount of required benzodiazepine,
cumulative benzodiazepine dose, incidence of severe AWS complications, and use of
adjunctive medications in the treatment of AWS.
Analysis of Results
The use of benzodiazepines appears to be the most frequently used
pharmacological agent for the use of AWS. There was a significant difference in results
found in the comparison studies of pharmacological drugs used. All of the studies consist
of different research methods, however, in 4 of the 7 studies reviewed it has been
concluded that by performing a risk assessment of AWS prior to symptoms occurring and
implementing early treatment assists with reducing the severity of AWS symptoms and
further complications.
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Chapter 3 – Methodology
Methodology
A survey questionnaire was developed to collect information to examine the
impact that the use of CIWA-Ar has on physicians and nurses at Central Arkansas
Veterans Healthcare System (CAVHS). The final data collection tool contained the
following variables:
1. Hospital setting
2. Healthcare professional job title
3. Number of AWS patients cared for by the healthcare professional in the past year
4. Amount of pharmaceutical treatments required while using CIWA-Ar
5. Length of stay while using CIWA-Ar
6. Ability to document CIWA-Ar template within one hour of following protocol
7. Efficiency of CIWA-AR with electronic charting
8. Whether or not CIWA-Ar effectively prevents the progression of AWS symptoms
9. Whether or not CIWA-Ar is the most sensitive tool used to treat AWS by
healthcare professional
10. Whether or not CIWA-Ar has positively or negatively impacted the healthcare
professionals care of patients with AWS
Variables and Rationale
1.

What type of unit do you work on? Survey choices were: (a) Critical care (b)
Acute care (c) Long-term care (d) Other.
Rationale: The healthcare setting can factor in how AWS is managed.
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2. What is your job title? Survey choices were: (a) Medical Doctor (b) Registered
Nurse (c) Licensed Practical Nurse.
Rationale: Physicians and nurses may have differing viewpoints on the effects of
CIWA-Ar protocol for AWS patients. Typically, physicians will see more of these
patients since they have a larger amount of patients that they see. Whereas, nurses
work more closely at the bedside with these patients.
3. On average how many patients have you cared for with alcohol withdrawal in the
past year? This survey question had an open ended answer.
Rationale: The healthcare professional that has seen a large number of these
patients are more likely to have a more substantiated view of the treatment of
patients with AWS.
4. In comparison to other interventions, did patients on CIWA-Ar protocol require
more or less pharmaceutical interventions? Survey choices were: (a) More (b)
Less (c) No changes (d) Other (specify).
Rationale: Whether or not patients required more or less pharmaceutical
interventions will affect the impact on healthcare professionals.
5. In comparison to other interventions, did patients on CIWA-Ar protocol length of
stay increase or decrease? Survey choices were: (a) Increase (b) Decrease (c)
No changes (d) Other (specify).
Rationale: Whether or not the AWS patient’s length of stay increased or
decreased will affect the impact on healthcare providers.
6. Are you able to document CIWA-Ar in a timely fashion (within 1 hour of
assessment)? Survey choices were: (a) Yes (b) No (Explanation optional).
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Rationale: The ability to document CIWA-Ar will affect the impact on healthcare
providers.
7. Do you think that CIWA-Ar management is more efficient with electronic
charting? Survey choices were: (a) Yes (b) No (Explanation optional).
Rationale: Healthcare providers’ perceptions on whether or not they are able to
efficiently use CIWA-Ar electronically will affect the impact.
8. Do CIWA-Ar interventions effectively prevent the progression of alcohol
withdrawal? Survey choices were: (a) Yes (b) No (Explanation optional).
Rationale: If CIWA-Ar interventions are able to effectively prevent the
progression of AWS then it will have an impact on care provided by healthcare
professionals.
9. Is the CIWA-Ar the most sensitive tool you have used for assessment of the
patient experiencing alcohol withdrawal? Survey choices were: (a) Yes (b)
No (Please provide explanation).
Rationale: The sensitivity of the CIWA-Ar tool will affect the impact on
healthcare providers.
10. Has the CIWA-Ar protocol positively or negatively impacted your care of alcohol
withdrawal patients? Survey choices were: (a) Positive impact (b) Negative
impact (c) No impact (Explanation optional).
Rationale: Healthcare providers’ perceptions of the impact of CIWA-Ar will
determine if they are more likely to endorse and comply with CIWA-Ar.

18

IMPACT OF CIWA-AR ON HEALTHCARE PROFESSIONALS
Database Selection
After receiving approval of the survey tool by the director and associate professor
of the University of Tennessee Healthcare Science’s health informatics and information
management graduate program, Drs. Rebecca Reynolds and Sajeesh Kumar, a database
was chosen to distribute and evaluate the survey data. Survey monkey was selected after
much consideration. It met the criteria for the collection of data that the researcher was
pursuing. Survey monkey has many features that aid in the gathering and analyzation of
survey data. In addition, it is user friendly for the creator of the survey as well as the
survey’s participants.
Data Collection Instrument
A data collection instrument was developed in Survey Monkey by entering the
survey questionnaire variables. The survey was distributed by providing the web address
link that allowed for quick and easy access to the survey tool. This data collection method
allowed for anonymity and consisted of 10 questions; 9 of the questions were multiple
choice and only 1 was fill in the blank.
Population and Sample Design
Physicians and nurses of the Central Arkansas Veterans Healthcare System
(CAVHS) were selected to participate in the survey. CAVHS’s healthcare professionals
were chosen because the researcher is employed at the facility as a registered nurse and
has encountered many patients with AWS in her profession. CIWA-Ar protocol was
implemented three years ago at CAVHS and the researcher was concerned with the
impact it had on patients and care provided by the healthcare providers. Due to the time
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constraints of the research project, it was most feasible to pursue answers from healthcare
professionals.
Data Collection Procedures
With permission from the proper CAVHS’s authorities, a group email (Figure 5)
was sent that detailed the research project and provided a web address link to the survey
questionnaire. The first email was sent September 10, 2015 and thereafter emails were
sent weekly with a deadline of October 10, 2015. Flyers were also posted throughout the
CAVHS facility (Figure 6).
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Chapter 4 – Results
Response Rate of Population
By the October 10, 2015 deadline, 87 responses were received. 5 of the
respondents were doctors, 81 of the respondents were registered nurses, 0 of the
respondents were licensed practical nurses, and 1 respondent did not specify. A specific
number of the physicians and nurses employed at the CAVHS in Little Rock, AR could
not be acquired.
Frequency and Contingency Tables
Summaries of the counts and percentages of the responses to each of the 10
survey questions are shown in the following tables and graphs. The first three tables
provide information on the healthcare professionals’ job characteristics and amount of
patients with AWS they typically work with yearly. Tables 3 through 10 display
information on the respondents’ beliefs and perceptions regarding the impact that CIWAAr has on care provided by healthcare professionals. Tables 11 through 14 provide
comparisons and Pearson’s Chi Square calculations of the significance between unit
types and the selected variables from the survey questionnaire. Tables 15 through 17
provide comparisons between MDs’ and RNs’ responses. Graphs 1 through 6 display
further comparisons between MDs’ and RNs’ answers to the survey questions. They are
as follows:
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Table 1: Hospital Setting
What type of unit do you work on?
UNIT TYPE

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

CRITICAL CARE

49

54.44%

ACUTE CARE

40

44.44%

LONG TERM CARE

0

0%

OTHER

1

1.11%

Note: There are 87 respondents. Some respondents work on multiple units and selected more than one unit.

Table 2: Healthcare Professional’s Job Title
What is your job title?
JOB TITLE

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

MD

5

5.75%

RN

81

93.10%

LPN

0

0.00%

UNKNOWN

1

1.15%
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Table 3: Yearly Total of AWS Patients Cared for by Healthcare Professional
On average how many patients have you cared for with alcohol withdrawal in the past
year?
YEARLY TOTAL OF AWS

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

0

0

0.00%

1-5

19

21.84%

6-10

28

32.18%

11-15

11

12.64%

16-20

9

10.34%

21-25

9

10.34%

26-30

5

5.75%

31-35

0

0.00%

36-40

1

1.15%

40-45

2

2.30%

50-55

3

3.45%

PATIENTS

Table 4: Amount of Pharmaceutical Treatments while on CIWA-Ar
In comparison to other interventions, did patients on CIWA-Ar protocol require more or
less pharmaceutical interventions?
AMOUNT OF PHARMACEUTICAL

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

MORE

50

57.47%

LESS

25

28.74%

NO CHANGES

11

12.64%

OTHER

1

1.15%

TREATMENTS

23

IMPACT OF CIWA-AR ON HEALTHCARE PROFESSIONALS
Table 5: Length of Stay while on CIWA-Ar
In comparison to other interventions, did patients on CIWA-Ar protocol length of stay
increase or decrease?
LENGTH OF STAY

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

INCREASE

32

36.78%

DECREASE

30

34.48%

NO CHANGES

23

26.44%

OTHER

2

2.30%

Table 6: Ability to Document CIWA-Ar Template within 1 Hour
Are you able to document CIWA-Ar in a timely fashion (within 1 hour of assessment)?
DOCUMENT WITHIN 1 HOUR

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

YES

66

75.86%

NO

19

21.84%

UNASWERED

2

2.30%

Table 7: Efficiency of CIWA-Ar with Electronic Charting
Do you think that CIWA-Ar management is more efficient with electronic charting?
EFFICIENT WITH ELECTRONIC

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

YES

82

94.25%

NO

5

5.75%

CHARTING
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Table 8: CIWA-Ar Effect on the Progression of AWS
Do CIWA-Ar interventions effectively prevent the progression of alcohol withdrawal?
EFFICIENT WITH ELECTRONIC

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

YES

75

86.21%

NO

12

13.79%

CHARTING

Table 9: Tool Sensitivity of CIWA-Ar
Is the CIWA-Ar the most sensitive tool you have used for assessment of the patient
experiencing alcohol withdrawal?
MOST SENSITIVE TOOL USED

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

YES

85

97.70%

NO

2

2.30%

FOR AWS

Table 10: Impact of CIWA-Ar on Care Provided by Healthcare Professionals
Has the CIWA-Ar protocol positively or negatively impacted your care of alcohol
withdrawal patients?
IMPACT OF CIWA-AR ON CARE

NUMBER OF RESPONSES

PERCENTAGE OF RESPONSES

POSITIVE

56

64.37%

NEGATIVE

9

10.34%

NONE

22

25.29%

25
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Table 11a: Cross Tabulation of Unit Type and Pharmaceutical Interventions
In comparison to other interventions, did patients on the CIWA-Ar protocol require more or less
pharmaceutical interventions?
What type of unit do you work on?
Critical
care

Acute care

Other

Critical
Care %

Acute
Care %

Other %

More
Less

28
13

24
12

1
0

31.46%
14.61%

26.97%
13.48%

1.12%
0.00%

No changes
Other (please specify)

7
0

4
0

0
0

7.87%
0.00%

4.49%
0.00%

0.00%
0.00%

Answer Options

answered question
skipped question

86
1

Table 11b: Pearson’s Chi Square Test of Unit Type and Pharmaceutical Interventions
Critical Care
Acute Care
Marginal Row Totals
28 (27.69) [0]
24 (24.31) [0]
52
More
13 (13.31) [0.01]
12 (11.69) [0.01]
25
Less
41
36
77 (Grand Total)
Marginal Column
Totals
The Chi-square statistic is 0.0231. The P value is 0.87916. This result is not significant at p < 0.05.

Table 12a: Cross Tabulation of Unit Type and Length of Stay
In comparison to other interventions, did patients on CIWA-Ar protocol length of stay increase or
decrease?
What type of unit do you work on?
Answer Options
Increase
Decrease
No Changes
Other (please specify)

Critical
care

Acute care

Other

Critical
Care %

Acute
Care %

Other %

22
15
11
0

12
15
12
1

0
0
1
0

24.72%
16.85%
12.36%
0.00%

13.48%
16.85%
13.48%
1.12%

0.00%
0.00%
1.12%
0.00%

answered question
skipped question

86
1
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Table 12b: Pearson’s Chi Square Test of Unit Type and Length of Stay
Critical Care
Acute Care
Marginal Row Totals
22 (19.66) [0.28]
12 (14.34) [0.38]
34
Increase
15 (17.34) [0.32]
15 (12.66) [0.43]
30
Decrease
37
27
64 (Grand Total)
Marginal Column
Totals
The Chi-square statistic is 1.4132. The P value is 0.23453. This result is not significant at p < 0.05.

Table 13a: Cross Tabulation of Unit Type and Documentation

Are you able to document CIWA-Ar in a timely fashion (within 1 hour of assessment)?
What type of unit do you work
on?
Answer Options
Yes
No

Critical
care

Acute care

Other

Critical
Care %

Acute Care
%

Other %

40
8

29
10

0
1

45.45%
9.09%

32.95%
11.36%

0.00%
1.14%

answered question
skipped question

85
2

Table 13b: Pearson’s Chi Square Test of Unit Type and Documentation
Critical Care
40 (38.07) [0.1]
8 (9.93) [0.38]
48

Acute Care
29 (30.93) [0.12]
10 (8.07) [0.46]
39

Marginal Row Totals
69
18
87 (Grand Total)

Yes
No
Marginal Column
Totals
The Chi-square statistic is 1.0561. The P value is 0.304103. This result is not significant at p < 0.05.
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Table 14a: Cross Tabulation of Unit Type and Perceived Impact
Has the CIWA-Ar protocol positively or negatively impacted your care of alcohol withdrawal
patients?
What type of unit do you work on?
Answer Options

Critical
care

Acute care

Other

Critical
Care %

Acute Care
%

Other %

Positive impact
Negative impact
No impact

29
6
14

28
3
9

0
1
0

32.22%
6.67%
15.56%

31.11%
3.33%
10%

0.00%
1.11%
0.00%

answered question
skipped question

87
0

Table 14b: Pearson’s Chi Square Test of Unit Type and Perceived Impact
Acute Care
Critical Care
Marginal Row Totals
3 (4.23) [0.36]
6 (4.77) [0.32]
9
Negative Impact
28 (26.77) [0.06]
29 (30.23) [0.05]
57
Positive Impact
31
35
66 (Grand Total)
Marginal Column
Totals
The Chi-square statistic is 0.778. The P value is 0.37776. This result is not significant at p < 0.05.

Table 15a: Comparison of MDs and RNs Perceived Impact
Has the CIWA-Ar protocol positively or negatively impacted your care of alcohol withdrawal
patients?
What is your job title?
Answer Options

MD

RN

Response Percent

Response Count

Positive impact

2

54

65.1%

56

Negative impact

2

7

10.5%

9

No impact

1

20

24.4%

21

answered question
skipped question

86
0
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Table 15b: Pearson’s Chi Square Test of MDs and RNs Perceived Impact
MDs
2 (3.26) [0.48]
2 (0.52) [4.17]
1 (1.22) [0.04]
5

Positive Impact
Negative Impact
No Impact
Column Totals

RNs
54 (52.74) [0.03]
7 (8.48) [0.26]
20 (19.78) [0.00]
81

Row Totals
56
9
21
86 (Grand Total)

The chi-square statistic is 4.9817. The p-value is .08284. The result is not significant at p < .05.

Table 16: Registered Nurses

RNS
TOTAL
RESPONDENTS

CRITICAL
CARE
54.32%
44

ACUTE CARE
45.68%

LONG-TERM
CARE
0.00%

OTHER

TOTAL

0.00%

100.00%

37

0

0

81

Table 17: Medical Doctors

MDS
TOTAL
RESPONDENTS

CRITICAL
CARE
80.00%
4

ACUTE CARE
20.00%

LONG-TERM
CARE
0.00%

OTHER

TOTAL

0.00%

100.00%

1

0

0

5
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Graph 1: Comparison of MDs and RNs Pharmaceutical Interventions

Graph 2: Comparison of MDs and RNs Length of Stay
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Graph 3: Comparison of MDs and RNs Documentation

Graph 4: Comparison of MDs and RNs Management with Electronic Charting
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Graph 5: Comparison of MDs and RNs Perception of Effectiveness

Graph 6: Comparison of MDs and RNs Perceived Impact of CIWA-Ar
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Analysis and Discussion
In the survey questionnaire, 54% of the respondents worked in a critical care unit,
44% of the respondents worked in an acute care unit, and 1% of the respondents selected
“other” (Table 1). In Table 2, 81 of the respondents were registered nurses, 5 of the
respondents were medical doctors, none of the respondents were licensed practical
nurses, and 1 of the respondents did not answer. In Table 3, respondents entered
anywhere from 2 to 50 patients that they have cared for with AWS. The majority was
thirty-two percent of the participants provided care for six to ten patients with AWS in
the past year. In Table 4, 57.47% of participants selected that they have to give more
pharmaceutical treatments while their patients are on CIWA-Ar protocol. Whereas,
28.74% respondents selected less, 12.64% respondents selected no changes, and 1.15%
respondents selected other. In Table 5, 36.78% of respondents selected that their patients’
length of stay increased while on CIWA-Ar, 34.48% respondents selected a decrease,
26.44% respondents selected no changes, and 2.30% of respondents did not respond. In
Table 6, 75.86% of respondents selected that they are able to document the CIWA-Ar
template within one hour, 21.84% selected that they are not able to document, and 2.30%
of respondents did not answer. In Table 7, 94.25% of respondents selected that they think
CIWA-Ar management is more efficient with electronic charting and 5.75% of
respondents selected no. In Table 8, 86.21% of respondents selected that they think that
CIWA-Ar interventions effectively prevent the progression of AWS and 13.79% of
respondents selected no. In Table 9, 97.70% of respondents selected that CIWA-Ar is the
most sensitive tool that they have used for patients experiencing AWS and only 2.30% of
respondents selected that it is not the most sensitive tool. In Table 10, 64.37% of
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respondents selected that CIWA-Ar has had a positive impact on the care that they
provided for patients with AWS, 10.34% selected that CIWA-Ar has had a negative
impact on the care that they provided for patients with AWS, and 25.29% selected that
CIWA-Ar has had no impact on the care that they provided for patients with AWS.
Cross Tabulations and Pearson’s Chi Square Tests
The Pearson’s Chi-Square test was chosen to determine if there was a statistical
relationship between pairs of selected survey variables at the 0.05 level of significance.
This test is often utilized to assess whether unpaired observations on two variables,
expressed in a contingency table, are independent of each other. At the 0.05 significance
level, none of the aforementioned variables were deemed to be significant of one another.
Likely reasons for this are: (1) The sample size was small in comparison to the number of
MDs and nurses that work at the facility (2) The time allotted may not have been enough
to get a larger amount of participants (3) Each respondent has cared for a wide range of
patients with AWS (4) Some of the respondents skipped answering the survey in its
entirety (5) In some of the questions, the answers allowed for multiple selections. Some
ways to address these issues are by: focusing solely on doctors or nurses in a specific unit
type; eradicating some of the answer choices so that there is a smaller chance of variance;
allowing for more time and sending more emails for greater participation; utilizing a
statistical test for smaller sample sizes.
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Chapter 5 – Conclusion and Recommendations
Summary of Findings
The data collected had interesting results. Percentage wise majority of the
healthcare professionals selected that patients with AWS required more pharmaceutical
interventions and had a longer length of stay. However, majority of the healthcare
professionals selected that: they were able to document the CIWA-Ar interventions
within one hour; CIWA-Ar was more efficient with electronic charting; CIWA-Ar was
the most sensitive tool they utilized for patients with AWS; and that utilizing CIWA-Ar
positively impacted the care that they provided for patients with AWS. Statistically
shown, these variables were independent of one another and there was not a correlation.
Nevertheless, there was a small sample size and a greater sample may have yielded
different results.
Implications of Study
As aforementioned, the research question is: What impact does the Clinical
Institute Withdrawal Assessment for Alcohol scale-revised (CIWA-Ar) have on care
provided by healthcare professionals? The survey questionnaire was able to provide a
spectrum of variables that can impact care provided while using the CIWA-Ar protocol.
Healthcare professionals can benefit from this by developing strategic plans within their
units and departments to increase the positive impact.
Recommendations
Some of the participants in their answers expressed in the optional explanations
that they had better results when patients received a scheduled and ordered amount of
liquor instead of benzodiazepines to decrease the progression of AWS. Perhaps this could
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further be looked into in order to integrate into CIWA-AR treatment and provide a more
effective management for patients. The research also brings up the question if healthcare
professionals were less inclined to comply with the CIWA-Ar protocol if they felt as if
using this tool had a negative impact on the care that they provided for their patients. In
addition, since MDs and RNs utilize the CIWA-Ar tool differently then further research
should look at these two groups independently.
Alcohol dependence and abuse is not only a problem nationwide, but also
worldwide. Individuals that voluntarily or involuntarily wish to stop their alcohol intake
must proceed cautiously, because they have a chance of developing AWS. AWS
symptoms can be mild or life threatening. A symptom based management tool known as
CIWA-Ar has been implemented in a lot of healthcare facilities. It is important to
determine if this is the best route of assessment and treatment for a substance that is
abused so often. With proper research and analysis, the safest and best approach can be
determined.
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APPENDIX A: SWOT ANALYSIS
Potential Future Research Topic: I am interested in researching the effectiveness of the clinical
institute withdrawal assessment for alcohol scale (CIWA-Ar) protocol used to prevent alcohol
withdrawal in patients admitted to the hospital I work at. The CIWA-Ar protocol has a set of ordered
guidelines and medical interventions that the healthcare providers use that is established by a scale
that scores the patient based upon the physiological alcohol withdrawal symptoms that he/she
displays.
………………………………………………………………………………………………………………………
MY STRENGTHS IN THIS RESEARCH

MY WEAKNESSES IN THIS RESEARCH

I have strong critical thinking, writing, organizational, and
computer skills.
I have professional firsthand knowledge and experience of
implementation and evaluation of CIWA-Ar protocol.
I already have computer access to patient records (upon
approval of facility).
I can utilize a database system and data extracts to condense
the information and choose the significant data of my
research, such as, gender, amount of alcohol intake, length of
alcohol consumption, previous incidents of alcohol
withdrawal, etc.
I have access to the overseers of the CIWA-Ar protocol at my
facility.

I have not previously performed a research project of
this capacity.
I have my own bias of the CIWA-Ar protocol.
There may not be enough time to collect all of the data
that I need if I do not receive approval from the facility
and IRB in a timely fashion. In order to mitigate this
weakness, I plan to determine if there is a previous
census that has kept track of the number of incidences
that used the CIWA-Ar protocol.

MY OPPORTUNITIES IN THIS RESEARCH

MY THREATS IN THIS RESEARCH

I will gain research experience and learn the process of
performing a research project.
I work at a facility that utilizes the CIWA-Ar protocol.
This research will help determine the benefits and challenges
of the CIWA-Ar protocol.
If beneficial, the CIWA-Ar protocol will greatly reduce
incidents of alcohol withdrawal which decreases incidents of
complications during hospitalization, longer hospital stay, and
greater expenses. If it is not, then other interventions should
be looked at to reduce alcohol withdrawal.

I will require research approval from my facility. I will
keep in mind HIPAA and use de-identification and other
redaction processes to protect sensitive information.
I will require research approval from IRB.
Not all of the physician residents use the CIWA-Ar
protocol order set and sometimes write their own orders,
which decreases uniformity.
I am unsure of the amount of incidences that the CIWAAr protocol was necessary, so there may not be enough
data available.
Patient’s full disclosure in the amount of alcohol intake
can delay implementation of CIWA-Ar protocol, which
can affect the effectiveness.

Notes: I am interested in the rates of alcohol withdrawal seen in facilities that supply patients with an ordered amount of
alcohol in comparison of those that implement the CIWA-Ar protocol, however, at this time I think that it is more
feasible and accessible to look at the effectiveness of CIWA-Ar protocol in the facility I work at. However, I will take it
into consideration as my research progresses.
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Figure 1: Literature Review Search

Search terms
established

Keywords online search
of CINAHL with full text,
PubMed, Google
Scholar, ERIC and Ovid
251 Articles

Removal of articles
without full text
54 Articles

Removal of articles that
abstracts did not meet
criteria
22 Articles

Removal of articles that
content did not meet
criteria
7 Articles
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Figure 2: CIWA-Ar Flowsheet Template
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Figure 3: Alcohol Admission Assessment
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Figure 4: CIWA-Ar Automated Order Set
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Figure 5: Research Email
Hello VA colleagues,
My name is LaRonda Tinsley and I am currently enrolled in the University of Tennessee
Health Science Center Health Informatics and Information Management Master’s
program. As a course requirement to obtain my degree, I must conduct a research project.
I am interested in learning the impact that the Clinical Institute Withdrawal Assessment
of Alcohol Scale-revised (CIWA-Ar) has on care provided by healthcare professionals. I
have created a survey questionnaire that can be found at:
https://www.surveymonkey.com/r/V8TZXQ5. The survey is anonymous and is composed
of 10 quick questions. If you have time, please fill it out by October 10, 2015. If you have
any questions please feel free to contact me at: larondatinsley@gmail.com or
laronda.tinsley@va.gov.
Thank you,
LaRonda Tinsley, BSN, RN
SICU
Ext. 74650
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Figure 6: Research Flyer

Physicians and Nurses
What impact does CIWA-Ar have on care that you
provide for patients?
Hello VA colleagues,
My name is LaRonda Tinsley and I have created a survey questionnaire to learn the
impact that the Clinical Institute Withdrawal Assessment of Alcohol Scale-revised
(CIWA-Ar) has on care provided by healthcare professionals. The survey can be
found at: https://www.surveymonkey.com/r/V8TZXQ5. It is anonymous and is
composed of 10 quick questions. If you have time, please fill it out by October 10,
2015. If you have any questions please feel free to contact me at:
larondatinsley@gmail.com or laronda.tinsley@va.gov.
Thank you,
LaRonda Tinsley, BSN, RN
SICU
Ext. 74650
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Chart 1: Comparison of Reviewed Studies
Authors of

Population

Pharmacological

Preventative

Treatments Used

Measures

ICU adult
patients
diagnosed
with AWS

Benzodiazepines
Ethanol infusion
Haloperidol

CAGE
questionnaire
Short Michigan
Alcohol
Screening test
CIWA-Ar
Protocol

57 adult
patients with
myocardial
infarction

Lorazepam
Ethanol infusion

CAGE
questionnaire

50 adult
inpatients
diagnosed
with AWS

Chlordiazepoxide

Pre-intervention
audit
CIWA-Ar

Adult
inpatients
diagnosed
with AWS

Clonidine
None
Dexmedetomidine
Placebo

Study
Awissi, Lebrun,
Coursin, Riker,
et. al (2012)

Fullwood,
Mostaghimi,
Granger, et. al

Results

Critically ill trauma patients
developing AWS have a longer
duration of mechanical
ventilation and ICU stay, more
frequent pneumonia, urinary
tract infections, sepsis, and
septic shock, and higher
Mortality.
Safety-associated complication
rates did not differ between
groups. Days spent in the
cardiac intensive care unit and
overall hospital stay did not
differ between the 2 groups.

(2013)
Murdoch &
Marsden
(2014)

Muzyk, Fowler,
Norwood, et al.
(2011)

Patients required significantly
less chlordiazepoxide to manage
AWS and not one person from
the sample group developed
severe signs of withdrawal. It is
deduced that this is due to the
patients being assessed more
frequently with a validated
individualized assessment tool,
in conjunction with staff having
an increased knowledge of the
withdrawal process.
Data from randomized, doubleblind studies support the
efficacy of oral and transdermal
clonidine in reducing symptoms
of alcohol withdrawal related to
sympathetic overdrive in
patients with mild-to-moderate
alcohol withdrawal. However,
the ability of clonidine
monotherapy to prevent alcohol
withdrawal seizures or alcohol
withdrawal delirium has not
been demonstrated.
Dexmedetomidine successfully
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Prince & Turpin
(2008)

Sohraby,
Attridge, &
Hughes
(2014)

Taheri, Dahri,
Chan, et al.
(2014)

Adult
inpatients
diagnosed
with AWS

Carbamazepine
Gabapentin
Nitrous oide

Total of 64
Propofol
mechanically Benzodiazepines
ventilated
adult
patients (18
and older)
with ICD- 9
codes of
AWS
97% males
with mean
age of 45
Total of 99
Benzodiazepines
individuals
70 and older
admitted to
the Acute
Care for
Elders and
Acute
Medicine
Unit wards
with
diagnostic
codes for
AWS

None

CIWA-Ar
protocol
implemented

CIWA-Ar
protocol
implemented
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controlled psychomimetic and
sympathetic symptoms of
withdrawal, an effect that was
seen almost immediately
following initiation of this
medication.
Carbamazepine, gabapentin, and
nitrous oxide have been
investigated
for the treatment of alcohol
withdrawal syndrome. Because
of limitations in evidence
accrued so far, the routine use of
carbamazepine and gabapentin
cannot be recommended, and
nitrous oxide should be avoided
for this indication.
Patients receiving propofolcontaining regimens experienced
8 days of AWS symptoms
compared with patients in the
benzodiazepine monotherapy
group, who experienced 7 days
of AWS symptoms. Hospital
and ICU lengths of stay were
similar between groups. No
significant difference was noted
between groups in days of
required mechanical ventilation.
A symptom-triggered protocol
for dosing of benzodiazepine
therapy in the management of
AWS in adults aged 70 and
older significantly reduced the
total duration of benzodiazepine
use, cumulative benzodiazepine
dose, incidence of severe AWS
complications, and use of
adjunctive medications in the
treatment of AWS.
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